Company News
Alembic Pharma Invests 45% in Canadian JV
Alembic Pharmaceuticals executed a Shareholders' Agreement to invest in a Canadian corporation.
The company will hold a 45% equity stake in the JV focused on Canadian pharmaceutical market.
The JV par
